Most dermatologists advise waiting 2–4 weeks before applying sunscreen directly to a Mohs surgical site, depending on the closure type (primary closure, flap, or graft) and how the wound is healing.

This creates a critical protection gap. The surgical site is maximally vulnerable to UV-induced hyperpigmentation during exactly the period when sunscreen cannot be applied. A UV umbrella bridges this gap completely—providing 99% UV blockage with zero skin contact from the moment the patient leaves your clinic. Many Mohs surgeons now include a UV umbrella in the discharge kit alongside wound care instructions.

There are two timelines to consider: cosmetic and cancer prevention.

For cosmetic outcomes (minimizing scar darkening and PIH), strict photoprotection is recommended for a minimum of 6 months post-surgery. The regenerating skin at the surgical site remains hypersensitive to UV throughout this period, and even brief unprotected exposure can cause permanent hyperpigmentation.

For cancer prevention, the answer is lifelong. Mohs patients have already demonstrated a high-risk phenotype for skin cancer. The Skin Cancer Foundation reports that patients who have had one skin cancer have a significantly elevated risk of developing additional primary cancers. Daily UV protection with a combination of sunscreen, physical shade, and protective clothing is the standard of care for long-term risk reduction.

No—a UV umbrella complements wound dressings, not replaces them.

In the immediate post-operative period, wound dressings serve multiple functions: moisture retention, infection prevention, mechanical protection, and some UV shielding at the surgical site. The umbrella provides an additional layer of overhead UV protection for the entire face and surrounding skin—areas that dressings do not cover.

Once dressings are removed (typically 1–2 weeks), the umbrella becomes the primary physical UV barrier until sunscreen can safely be applied. It then continues as a complementary tool alongside sunscreen for the full 6+ month healing period and beyond.

Yes—and suture removal is actually one of the most important moments to start using it.

When sutures are removed (typically 5–14 days post-Mohs), the wound site loses the physical protection provided by dressings. The newly exposed scar tissue is extremely vulnerable to UV. Since sunscreen may still not be advisable on the fresh scar for another 1–2 weeks, the umbrella fills this protection gap.

A UV umbrella requires absolutely zero skin contact—it provides overhead physical shade at a distance. There is no risk of disturbing the healing tissue, pulling at scar margins, or introducing irritants to the wound site. Many Mohs surgeons provide the umbrella at the suture removal appointment as part of the next-phase aftercare instructions.

While specific Mohs-only PIH rates vary by study design and patient population, the available evidence is clear on the direction and magnitude of the effect.

Post-inflammatory hyperpigmentation occurs in an estimated 20–40% of surgical wounds on sun-exposed areas when photoprotection is inconsistent, with rates highest in Fitzpatrick skin types III–VI. For Mohs sites specifically—which are predominantly on the head and neck (the most sun-exposed areas)—the risk is at the upper end of this range.

Rigorous multi-modal photoprotection (broad-spectrum sunscreen + physical shade + avoidance of peak UV hours) has been shown to reduce PIH incidence by 50–70% in post-surgical cohorts. Adding a physical shade component like a UV umbrella addresses the known failure mode of sunscreen-only protocols: poor real-world adherence. The practical effect is that patients who carry an umbrella maintain more consistent protection than those relying on sunscreen reapplication alone.